7T Magnetic Resonance Imaging Systems Market Size:
7T Magnetic Resonance Imaging Systems Market was valued at USD 2.01 billion in 2023 and is expected to reach USD 3.78 billion by 2032, growing at a CAGR of 7.26% from 2024-2032.
The 7T Magnetic Resonance Imaging (MRI) Systems market is experiencing growth because of the worldwide pace of advancement in imaging technology, and many high-resolution diagnostic tools are needed in both healthcare and research settings. Ultra-high-field MRI systems offer superior image resolution for the comprehensive study of neurodegenerative diseases, musculoskeletal disorders, and other complicated conditions. Because of their superior anatomical and functional imaging capability, thus, it have been recognized as a vital tool in clinical practice as well as in research applications.
Siemens Healthineers, for instance, was granted FDA clearance for its MAGNETOM Terra. X in March 2024. They launched a second-generation clinical 7 structure MRI scanner with new hardware and XA60A software. This new feature greatly improves scanning quality, further consolidating Siemens' leading position in the ultra-high-field MRI market. Likewise, the University of Florida purchased a Bruker 7T preclinical scanner in May 2023 with a USD 2 million NIH High-End Instrumentation Award, reflecting a growing investment in preclinical imaging research.
Other vital aspects fuelling the market growth are the rising cases of neurological disorders like Alzheimer's and multiple sclerosis, requiring accurate imaging for diagnosis and treatment, among others. World Health Organization estimates show that neurological disorders cause over 20% of DALYs worldwide, demonstrating the urgent and pressing need for improved diagnostic tools as provided by the 7T MRI systems.
Other major trends are the embedding of more AI/machine learning into scanning protocols to enable greater imaging precision, shortening acquisition time, etc. Also, governments at least are investing more and more infrastructure and funds, and increasing interdisciplinary collaborations across industry, academia, and governments in the process of using 7T MRI scanners for preclinical and translational studies.
Market Dynamics
Drivers
A growing global disease burden of neurological and chronic diseases drives the 7T Magnetic Resonance Imaging (MRI) systems market forward.
Conditions that are diagnosed as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy all require an exceptionally high definition in imaging diagnostics and treatment. The World Health Organization states that neurological disorders are responsible for over 20% of DALYs worldwide. Therefore, it is imperative to have more sophisticated diagnostic tools. 7T MRI systems boast a resolution and sensitivity that allow clinicians to visualize even the slightest structural and functional abnormalities, making it possible for early diagnosis and, subsequently, a more personalized approach to treatment. This increasing demand for high-resolution imaging is driving the adoption of 7T MRI systems in various clinical and research settings.
The growth in the 7T MRI systems market is fueled by the constant improvement in MRI technology and rising research funding.
Improved gradient systems, better signal-to-noise ratios, and integration with artificial intelligence (AI) for better image analysis are some of the continuous developments in MRI technology that are making 7T MRI scanners more efficient and accurate. These technological advancements enhance the resolution and capabilities of 7T MRI systems, making them capable of providing superior imaging that is needed for diagnosing complex conditions like neurological disorders, cancer, and musculoskeletal diseases.
Increasing funding for research, especially from government agencies, private organizations, and academic institutions, is accelerating the development and adoption of 7T MRI technology. Financial assistance is no longer enabling manufacturers to improve the technical features of these high-field MRI systems; it is also allowing them to be implemented in research settings in both clinical and preclinical environments. Therefore, with enhanced imaging capabilities and more significant research possibilities, 7T MRI systems emerge as an essential tool in enhancing medical diagnostics and scientific research, thereby fueling further expansion in the market.
Restraint
The 7T Magnetic Resonance Imaging (MRI) systems market is limited by very high purchase, installation, and maintenance costs associated with such advanced systems.
The price of a 7T MRI scanner may lie among several millions of dollars, and it turns into a serious investment for hospitals, research establishments, and diagnostic facilities. Specialized shielding and space requirements required for nuclear reactors also contribute to the total cost.
Limited access is a very important challenge, particularly in developing economies, where healthcare budgets are constrained and advanced medical technologies are scarce. A shortage of trained personnel to operate and interpret the results from 7T MRI systems is also lacking in some regions. Consequently, not only is the high cost of 7T MRI systems prohibitive, but so is the limited accessibility, restricting their wide-scale deployment primarily to well-funded research institutions and top-tier hospitals, especially in developed countries.
Segment Analysis
By Application
The research segment dominated the market and accounted for the maximum market share at 68% in 2023. This can be mainly because of increased research. Academic institutions and medical research centers invest more in advanced imaging technologies to study complex neurological and physiological conditions. Consequently, there has been a greater demand for 7T MRI systems. This high-resolution imaging capability becomes very useful especially in research studies, allowing deeper studies and breakthrough discoveries. For example, the publication of NCBI stated that the human spinal cord, 7 Tesla MRI has successfully been demonstrated at several research institutions around the globe. The spinal cord remains the most important location where higher strengths and higher resolutions can be gained. As a result, the expanding applications in research are expected to further fuel market growth.
The clinical application segment is likely to experience the fastest CAGR of more than 8.3% over the forecast period. This growth is majorly due to increasing applications and growing government approvals for clinical use. For example, a July 2023 article from the Mayo Clinic shows an interest in the clinical use of ultrahigh field 7T MRI in managing epilepsy and multiple sclerosis (MS). Mayo Clinic neuroradiologists, however, have expanded the use of 7T MRI in the clinical arena beyond the above-mentioned common applications. They now regularly employ this high-tech technology to guide treatment for patients with neurodegenerative disorders, cerebrovascular disease, amyotrophic lateral sclerosis (ALS), and other neurological conditions.
By End Use
The research institutes segment dominated the market with over 65% share in 2023. This is due to the increasing focus on advanced imaging technologies in academic and medical research institutions, which are driving the adoption of 7T MRI systems for studying complex neurological and physiological conditions. The other point is that funding and grants also reach the research institutes, helping them fund expensive technologies like 7T MRI for furthering their research. They can, with such funds, pursue large-scale studies and clinical trials, which involve the type of detailed imaging such systems can deliver.
Among the hospital segments, the 7T MRI market is expected to grow at the fastest CAGR over the forecast period. This is due to the increasing adoption of advanced imaging technologies in hospitals for enhanced diagnostic accuracy and patient results. These institutions are among the first to explore complex neurological and physiological conditions, such as neurodegenerative diseases, multiple sclerosis (MS), and epilepsy. Additionally, regulatory approvals for the clinical use of 7T MRI systems are increasing across the globe, making it easier for hospitals to incorporate these systems into routine medical care.
Regional Analysis
In 2023, North America dominated the market with a market share of 40%. This is due to the region's well-established healthcare infrastructure, which supports the extensive adoption of advanced medical technologies like 7T MRI systems. Favorable reimbursement policies and substantial healthcare spending in North America also facilitate broad access to 7T MRI technology for both patients and healthcare providers.
The Asia Pacific region is expected to have the fastest CAGR of 8.50% for the 7T magnetic resonance imaging systems market in the forecast period, driven by the rapid development of healthcare infrastructure in emerging economies such as China, India, and Japan. Governments and private sectors in these countries are investing heavily in the expansion of healthcare facilities, including hospitals and diagnostic centers, to improve the quality of medical care. In China, the market is expected to grow significantly, driven by an aging population and the increasing prevalence of chronic conditions such as neurological and cardiovascular disorders, which require high-resolution imaging systems like 7T MRI for superior diagnostic accuracy. Similarly, Japan is expected to see market growth shortly, driven by medical research advancements and innovation. This is bolstered by solid collaborations between universities, research institutions, and the healthcare industry.
Key Market Players
Siemens Healthineers
MAGNETOM Terra: The first 7T MRI scanner for clinical use, designed for advanced neuroimaging and musculoskeletal applications.
MAGNETOM Terra.X: An advanced version of the Terra, offering enhanced imaging capabilities and designed for clinical and research purposes.
GE HealthCare
SIGNA 7T MRI Scanner: Equipped with UltraG gradients, this scanner delivers superior contrast and signal-to-noise ratio (SNR) performance for improved diagnostic confidence.
Bruker BioSpin
BioSpec 70/30 USR: A 7T MRI system designed for preclinical and research applications, offering ultra-high resolution imaging.
BioSpec 70/20 USR: Another 7T MRI system from Bruker, tailored for small animal imaging with high sensitivity and resolution.
koninklijke philips nv
Philips Achieva 7T MRI: A cutting-edge, ultra-high-field MRI system designed to provide exceptionally detailed images for both clinical and research purposes.
Key suppliers
key suppliers that provide components, raw materials, or manufacturing services for personal mobility devices such as wheelchairs, scooters, and walkers:
Siemens Healthineers Suppliers
Avante Health Solutions Suppliers
GE HealthCare Suppliers
Providian Medical Equipment Suppliers
Bruker BioSpin Suppliers
Scintica Instrumentation Suppliers
Philips Healthcare Partners Suppliers
Henry Schein Medical Suppliers
Agiliti Health Suppliers
Amber Diagnostics Suppliers
Recent Developments
In March 2024, Siemens Healthineers announced that it received FDA clearance for the MAGNETOM Terra.X, its second-generation clinical 7-tesla magnetic resonance imaging (MRI) scanner. This advanced system integrates cutting-edge hardware and the XA60A software, significantly enhancing the capabilities of 7T MR scanning for clinical and research applications.
In May 2023, researchers at the University of Florida revealed plans to acquire a state-of-the-art Bruker 7 Tesla MRI/MRS preclinical scanner. The initiative is supported by a USD 2 million NIH High-End Instrumentation Award, enabling groundbreaking advancements in preclinical imaging research.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 2.01 Billion |
| Market Size by 2032 | US$ 3.78 Billion |
| CAGR | CAGR of 7.26% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Application (Clinical, Research) • By End Use (Hospitals and Clinics, Research Institutions, Diagnostic Imaging Centers) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Siemens Healthineers, GE HealthCare, Bruker BioSpinand other players. |
| Key Drivers | •A growing global disease burden of neurological and chronic diseases drives the 7T Magnetic Resonance Imaging (MRI) systems market forward •The growth in the 7T MRI systems market is fueled by the constant improvement in MRI technology and rising research funding |
| Restraints | •The 7T Magnetic Resonance Imaging (MRI) systems market is limited by very high purchase, installation, and maintenance costs associated with such advanced systems |
Ans- The 7T Magnetic Resonance Imaging Systems Market was valued at USD 2.01 billion in 2023 and is expected to reach USD 3.78 billion by 2032.
Ans – The CAGR rate of the 7T Magnetic Resonance Imaging Systems Market during 2024-2032 is 7.26%.
Ans- The research segment dominated the market by 65%
Ans- North America held the largest revenue share by 40%.
Ans- Asia Pacific is the fastest-growing 7T Magnetic Resonance Imaging Systems Market region.
Table of Content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
5. Statistical Insights and Trends Reporting
5.1 Adoption Rate of 7T MRI Systems in Hospitals and Research Institutions
5.2 Technological Advancements and Patent Filings
5.3 Investment and Funding in Research and Development
5.4 Healthcare Spending Allocation, by Region, (2023)
5.5 Adoption Rate and Installation Base (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. 7T Magnetic Resonance Imaging (MRI) Systems Market Segmentation, by Application
7.1 Chapter Overview
7.2 Clinical
7.2.1 Clinical Market Trends Analysis (2020-2032)
7.2.2 Clinical Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Research
7.3.1 Research Market Trends Analysis (2020-2032)
7.3.2 Research Market Size Estimates and Forecasts to 2032 (USD Billion)
8. 7T Magnetic Resonance Imaging (MRI) Systems Market Segmentation, by End User
8.1 Chapter Overview
8.2 Hospitals & Clinics
8.2.1 Hospitals & Clinics Market Trends Analysis (2020-2032)
8.2.2 Hospitals & Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Research Institutions
8.3.1 Research Institutions Market Trends Analysis (2020-2032)
8.3.2 Research Institutions Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Diagnostic Imaging Centers
8.4.1 Diagnostic Imaging Centers Market Trends Analysis (2020-2032)
8.4.2 Diagnostic Imaging Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.2.4 North America 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.2.5.2 USA 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.2.6.2 Canada 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.2.7.2 Mexico 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.1.5.2 Poland 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.1.6.2 Romania 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.1.7.2 Hungary 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.1.8.2 Turkey 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.4 Western Europe 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.5.2 Germany 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.6.2 France 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.7.2 UK 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.8.2 Italy 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.9.2 Spain 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Healthcare Predictive Analytic Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.12.2 Austria 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.4 Asia Pacific 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.5.2 China 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.5.2 India 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.5.2 Japan 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.6.2 South Korea 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.2.7.2 Vietnam Healthcare Predictive Analytic Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.8.2 Singapore 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.9.2 Australia 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.1.4 Middle East 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.1.5.2 UAE 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.1.6.2 Egypt 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.1.8.2 Qatar 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.2.4 Africa 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.2.5.2 South Africa 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.2.7.2 Rest of Africa 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.6.4 Latin America 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.6.5.2 Brazil 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.6.6.2 Argentina 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.6.7.2 Colombia 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America 7T Magnetic Resonance Imaging (MRI) Systems Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10. Company Profiles
10.1 Siemens Healthineers
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 GE HealthCare
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Bruker BioSpin
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Koninklijke Philips NV
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Application
Clinical
Research
By End Use
Hospitals and Clinics
Research Institutions
Diagnostic Imaging Centers
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization to meet the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Vitamins Market size was valued at USD 5.93 billion in 2023 and is expected to reach USD 10.54 billion by 2032 and grow at a CAGR of 6.64%.
The Dose Calibrator Market Size was valued at USD 1.5 Billion in 2023 and is expected to reach USD 2.1 Billion by 2032 and grow at a CAGR of 3.9% over the forecast period 2024-2032.
The Healthcare Contract Research Organization Market Size was valued at USD 50.5 billion in 2023 and is expected to reach USD 88.07 billion by 2031, and grow at a CAGR of 7.2% over the forecast period 2024-2031.
Microcatheters Market was valued at USD 0.94 billion in 2023 and is expected to reach USD 1.53 billion by 2032, growing at a CAGR of 5.53% from 2024 to 2032.
Heart Valve Devices Market Size was valued at USD 11.7 billion in 2023 and is expected to reach USD 33.2 billion by 2032, growing at a CAGR of 12.3% over the forecast period 2024-2032.
The Recombinant Proteins Market size was USD 2.5 billion in 2023 and is expected to reach USD 5.0 billion by 2032 with a growing CAGR of 7.6% by 2023-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
